New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
COVID-19
ageusia
anosmia
gustatory dysfunction
olfactory dysfunction
vaccination
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
12
11
2021
received:
19
10
2021
accepted:
16
11
2021
pubmed:
24
11
2021
medline:
19
1
2022
entrez:
23
11
2021
Statut:
ppublish
Résumé
The aim of this study is to investigate the clinical profile of patients who developed coronavirus disease 2019 (COVID-19) after full vaccination. Demographic, epidemiological and clinical data were collected through medical records and online patient-reported outcome questionnaire from patients who developed symptomatic SARS-CoV-2 infection, confirmed by nasopharyngeal swab, at least 2 weeks after completion of vaccination. A total of 153 subjects were included. The most frequent symptoms were: asthenia (82.4%), chemosensory dysfunction (63.4%), headache (59.5%), runny nose (58.2%), muscle pain (54.9%), loss of appetite (54.3%), and nasal obstruction (51.6%). Particularly, 62.3% and 53.6% of subjects reported olfactory and gustatory dysfunction, respectively. Symptom severity was mild or moderate in almost all cases. Chemosensory dysfunctions have been observed to be a frequent symptom even in subjects who contracted the infection after full vaccination. For this reason, the sudden loss of smell and taste could continue to represent a useful and specific diagnostic marker to raise the suspicion of COVID-19 even in vaccinated subjects. In the future, it will be necessary to establish what the recovery rate is in these patients. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:419-421, 2022.
Identifiants
pubmed: 34812498
doi: 10.1002/lary.29964
pmc: PMC9011575
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
419-421Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Am J Otolaryngol. 2022 Jan-Feb;43(1):103170
pubmed: 34391165
Chem Senses. 2021 Jan 1;46:
pubmed: 34423831
J Laryngol Otol. 2021 Aug;135(8):723-728
pubmed: 34184623
J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9
pubmed: 33221383
Laryngoscope. 2021 Oct;131(10):2312-2318
pubmed: 34287905
Otolaryngol Head Neck Surg. 2021 Nov 23;:1945998211061511
pubmed: 34813382
Rhinology. 2021 Dec 1;59(6):517-527
pubmed: 34553706
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
Int Forum Allergy Rhinol. 2021 Aug;11(8):1280-1282
pubmed: 33864717
Laryngoscope. 2020 Nov;130(11):2680-2685
pubmed: 32794209
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Acta Otolaryngol. 2021 Jun;141(6):615-620
pubmed: 33733988
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428
Eur J Neurol. 2021 Nov;28(11):3702-3711
pubmed: 34157187
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):515-520
pubmed: 33963433
J Intern Med. 2021 Aug;290(2):421-429
pubmed: 33527495
J Laryngol Otol. 2021 May;135(5):436-441
pubmed: 33888166
Int Forum Allergy Rhinol. 2022 Jan;12(1):103-107
pubmed: 34296541
Laryngoscope. 2021 May;131(5):1095-1100
pubmed: 33404079
Laryngoscope. 2021 Apr;131(4):865-878
pubmed: 33219539
Pathogens. 2021 Jan 12;10(1):
pubmed: 33445604